Prosecution Insights
Last updated: April 19, 2026
Application No. 17/937,485

METHODS FOR IMPROVING FLORET FERTILITY AND SEED YIELD

Non-Final OA §103
Filed
Oct 03, 2022
Examiner
MEADOWS, CHRISTINA L
Art Unit
1663
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Pairwise Plants Services Inc.
OA Round
3 (Non-Final)
73%
Grant Probability
Favorable
3-4
OA Rounds
2y 10m
To Grant
99%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allow Rate
43 granted / 59 resolved
+12.9% vs TC avg
Strong +26% interview lift
Without
With
+26.2%
Interview Lift
resolved cases with interview
Typical timeline
2y 10m
Avg Prosecution
34 currently pending
Career history
93
Total Applications
across all art units

Statute-Specific Performance

§101
8.8%
-31.2% vs TC avg
§103
27.2%
-12.8% vs TC avg
§102
16.2%
-23.8% vs TC avg
§112
42.0%
+2.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 59 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 01/02/2026 has been entered. Information Disclosure Statement Initialed and dated copy of Applicant’s information disclosure statement (IDS) filed on 01/02/2026 is attached to the instant Office Action. The submission is in compliance with the provisions of 37 CFR 1.97. Accordingly, the information disclosure statement is being considered by the examiner. Status of Claims The amendments received on 01/02/2026 have been entered. Claims 66, 69-70, 76, 78, 87-88, and 118-130 are pending. Claims 66, 69-70, 76, 78, and 87 remain withdrawn for being directed to a non-elected invention(s). Claims 88 and 118-130 are examined in this Office Action. The text of those sections of Title 35, U.S. Code, not included in this action, can be found in a prior Office action. Claim Rejections - 35 USC § 103 Claims 88 and 118-130 are rejected under 35 U.S.C. 103 as being unpatentable over Youssef (Youssef et al., 2017, Nature Genetics, Vol. 49(1), pp. 157-161; included on IDS dated 03/14/2023). All dependent claims are included in these rejections unless they include a limitation that overcomes the deficiencies of the parent claim. Claim 88 recites “[a] guide nucleic acid that binds to a target site in a corn Short Internodes (SHI) transcription factor gene that encodes a SHI transcription factor, wherein the SHI transcription factor is a SIX-ROWED SPIKE 2 (VRS2) transcription factor, and wherein the target site encodes a sequence having at least 80% sequence identity to any one of the amino acid sequences of SEQ ID NOs:88-92”. Youssef teaches the Six-rowed spike 2 (Vrs2), which encodes a SHORT INTERNODES (SHI) transcriptional regulator (i.e., a Short Internodes (SHI) transcription factor gene that encodes a SHI transcription factor, wherein the SHI transcription factor is a SIX-ROWED SPIKE 2 (VRS2) transcription factor) (Youssef, Abstract). Youssef teaches the SHI protein encoded by Vrs2 features two N-terminal zinc-finger-like motifs (CCCH) with a nuclear localization signal (KRRER) and the C-terminal SHI-family-specific IGGH domain (see sequence comparisons below) (Youssef, page 159, right column, last paragraph; Supplementary Figure 3). Youssef teaches that based on the IGGH domain, 111 SHI-related proteins were identified, including 6 in the barley genome, 4 in Brachypodium distachyon, 6 in rice (Oryza sativa L.), 5 in Sorghum bicolor and 10 in maize (Zea mays L.) (i.e., a corn Short Internodes (SHI) transcription factor gene that encodes a SHI transcription factor) (Youssef, page 159, right column, last paragraph; Supplementary Figure 4). PNG media_image1.png 488 1083 media_image1.png Greyscale The alignment shows the double-CCCH motif (red stars), the nuclear localization signal (KRRER), the IGGH domain (isoleucineglycine-glycine-histidine sequence) (the recited motifs are in bold in the instant sequence below). INSTANT SEQUENCE SEQ ID NO: 71(instant sequence SEQ ID NO: 88 in box): [AltContent: rect]MAGFPLGGGSHTQSRDAPASSVPPVHPSDAASFLYAARAGAGLQLWQQQQQHPFYTSNIIRFSDDPPGPAPSLTGATSPSHRTRASGGSGGGGGVSCQDCGNQAKKDCVHQRCRTCCKSRGFACSTHVKSTWVSAAKRRERQQQLAALAASAGDTAAAAGPSRDPTKRPRARLSVVTPTTTSSGDQQMVTVAERFPREVSSEALFRCVRLGPVDRAEAEVAYQTTVSIGGHVFKGLLHDVGPRSLPAAGGGAAAAAIEYYFRHAADGSPPSTTGAAGEACGAGGVGNVVVSSAVVMDPYPTPGSYAAFLPGAPFFPGGHPRQ Youssef teaches sequence A0A1I9RHG9_HORVU (UniProt) which shares 96.8% sequence identity with instant sequence SEQ ID NO: 88 (i.e., wherein the target site encodes a sequence having at least 80% sequence identity to SEQ ID NO: 88) (see sequence alignment below). Qy 1 CQDCGNQAKKDCVHQRCRTCCKSRGFACSTH 31 |||||||||||| |||||||||||||||||| Db 106 CQDCGNQAKKDCQHQRCRTCCKSRGFACSTH 136 It is noted that instant sequence SEQ ID NO: 71 also comprises instant sequences SEQ ID NO: 90 (100% sequence identity to instant sequence SEQ ID NO: 71; instant claim 123); SEQ ID NO: 91 (87.8% sequence identity to instant sequence SEQ ID NO: 71; instant claim 120); and SEQ ID NO: 92 (100% sequence identity to instant sequence SEQ ID NO: 71; instant claim 120). Youssef teaches mutant barley plants carrying the vrs2.e allele, which comprises an X-ray induced mutation resulting in a single-base-pair deletion at nucleotide position 527 in the first exon resulting in a frameshift mutation (Youssef, page 159, right column, first paragraph; Supplementary Note Table 1). Additionally, Youssef teaches mutants int-b.3 (deletion identical to that in vrs2.e allele), int-b.6 (a 13-bp deletion in exon 1), and HOR 19366 (a single-base-pair deletion at nucleotide position 504), all of which produce the same premature stop codon (see figure below). In the absence of evidence to the contrary, the deletions taught by Youssef, which introduce a premature stop codon, are capable of disrupting the binding of the SHI family transcription factor to DNA. PNG media_image2.png 347 685 media_image2.png Greyscale It is noted that it is the position of this Office that any mutation introduced using any guide system in any gene location that disrupts the binding of DNA is rendered obvious by the teachings of Youssef. Although Youssef does not explicitly teach introducing a mutation using an editing system that comprises a guide nucleic acid, there is no way to distinguish a corn plant comprising a mutation introduced using an editing system that comprises a guide nucleic acid from a corn plant comprising a mutation introduced via X-ray, for example. As such, it would have been obvious to one of ordinary skill in the art to introduce a mutation in the location of the VRS2 gene as taught by Youssef to disrupt DNA binding. At the time the instant application was filed, it would have been obvious and within the scope of one of ordinary skill in the art to utilize the known SHI transcription factor gene from barley as taught by Youssef, to identify a SHI transcription factor gene from maize which encodes the VRS2 transcription factor having at least 80% sequence identity to the amino acid of instant SEQ ID NO: 88, as taught by Youssef. Based on the teachings of Youssef, one of ordinary skill in the art would be motivated to mutate a maize VRS2 transcription factor gene knowing that the vrs2 mutants in barley produced premature stop codons. Thus, one of ordinary skill in the art would have a high expectation of success by following the teachings of Youssef. The method of mutating an endogenous gene to disrupt DNA binding is a technique that was routine in the art at the time the application was filed, as taught by the cited reference and the state of the art in general. In regard to claim 118, amino acid sequence A0A1I9RHG9_HORVU (UniProt) taught by Youssef, which shares 96.8% sequence identity with instant sequence SEQ ID NO: 88, is encoded by sequence KX601716.1 Hordeum vulgare mutant SHI (Vrs2) gene, vrs2.e allele, complete cds which shares 94% sequence identity with instant sequence SEQ ID NO: 75 (elected sequence; see alignment below) (i.e., wherein the target site comprises a sequence having at least 80% identity to the nucleotide sequence SEQ ID NO: 75). Sequence ID: KX601716.1 aligned with instant sequence SEQ ID NO: 75 Query 15 CAGCTGCCAGGACTGCGGCAACCAGGCCAAGAAGGACTGCGTGCACCAGCGCTGCCGCAC 74 |||||||||||||||||||||||||||||||||||||||| |||||||||||||||||| Sbjct 1024 CAGCTGCCAGGACTGCGGCAACCAGGCCAAGAAGGACTGCCAGCACCAGCGCTGCCGCAC 1083 Query 75 CTGCTGCAAAAGCCGCGGCTTCGCCTGCAGCACCCACGTCAAGTCCACCTGGGT 128 |||||||||| ||| |||||||||||| |||||||||||||||||||||||| Sbjct 1084 CTGCTGCAAATCCCGGGGCTTCGCCTGCTCCACCCACGTCAAGTCCACCTGGGT 1137 Summary No claim is allowed. Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHRISTINA MEADOWS whose telephone number is (703)756-1430. The examiner can normally be reached Monday - Friday 9:00 am - 5:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Amjad Abraham can be reached on 571-270-7058. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CHRISTINA L MEADOWS/Examiner, Art Unit 1663 CHRISTINA MEADOWS Examiner Art Unit 1663 /Amjad Abraham/SPE, Art Unit 1663
Read full office action

Prosecution Timeline

Oct 03, 2022
Application Filed
Dec 05, 2022
Response after Non-Final Action
Apr 17, 2025
Non-Final Rejection — §103
Jul 18, 2025
Response Filed
Aug 29, 2025
Final Rejection — §103
Oct 28, 2025
Response after Non-Final Action
Dec 04, 2025
Interview Requested
Dec 10, 2025
Applicant Interview (Telephonic)
Dec 10, 2025
Examiner Interview Summary
Jan 02, 2026
Request for Continued Examination
Jan 06, 2026
Response after Non-Final Action
Feb 23, 2026
Non-Final Rejection — §103
Mar 29, 2026
Interview Requested
Apr 09, 2026
Applicant Interview (Telephonic)
Apr 09, 2026
Examiner Interview Summary

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599093
SOYBEAN CULTIVAR 20372402
2y 5m to grant Granted Apr 14, 2026
Patent 12588612
PARTHENOCARPIC WATERMELON PLANTS
2y 5m to grant Granted Mar 31, 2026
Patent 12590317
POLYNUCLEOTIDES AND METHODS FOR TRANSFERRING RESISTANCE TO ASIAN SOYBEAN RUST
2y 5m to grant Granted Mar 31, 2026
Patent 12588613
Wheat Variety G18C2097
2y 5m to grant Granted Mar 31, 2026
Patent 12577579
Cytoplasmic Male-Sterile Rudbeckia Plants and a Method of Production
2y 5m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
73%
Grant Probability
99%
With Interview (+26.2%)
2y 10m
Median Time to Grant
High
PTA Risk
Based on 59 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month